Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates

Cell Death and Differentiation

Volumn 21, Issue 7, 2014, Pages 1132-1141

  Bae, E J ^a,b   Lee, H J ^b,c   Jang, Y H ^d   Michael, S ^e   Masliah, E ^e   Min, D S ^d   Lee, S J ^a,b  

^a Konkuk University   (South Korea)

^b Konkuk University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Pusan National University   (South Korea)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; PHOSPHOLIPASE D1; POLYUBIQUITIN; PROTEIN P62; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; PHOSPHOLIPASE D; PROTEIN AGGREGATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BRAIN TISSUE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; EMBRYO; ENZYME ACTIVITY; LYSOSOME; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; AGED; ENZYMOLOGY; FEMALE; HUMAN; LEWY BODY; MALE; METABOLISM; PARKINSON DISEASE; PHAGOSOME; PHYSIOLOGY; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AUTOPHAGY; CELL LINE, TUMOR; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; PARKINSON DISEASE; PHAGOSOMES; PHOSPHOLIPASE D; PROTEIN AGGREGATES;

EID: 84902266821     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.30     Document Type: Article

References (45)

1. Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007; 9: 1102-1109.
2. Jeong H, Then F, Melia TJ Jr, Mazzulli JR, Cui L, Savas JN et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 2009; 137: 60-72.
3. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
4. Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 2012; 8: 108-117.
5. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
6. Kim C, Lee S-J. Controlling the mass action of alpha-synuclein in Parkinson's disease. J Neurochem 2008; 107: 303-316.
7. Roth MG. Molecular mechanisms of PLD function in membrane traffic. Traffic 2008; 9: 1233-1239.
8. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL et al. Design of isoformselective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 2009; 5: 108-117.
9. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326.
10. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 1998; 23: 33-42.
11. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3: 452-460.
12. Lee H-J, Khoshaghideh F, Patel S, Lee S-J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004; 24: 1888-1896.
13. Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278: 25009-25013.
14. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3: 331-338.
15. Yoon MS, Yon C, Park SY, Oh DY, Han AH, Kim DS et al. Role of phospholipase D1 in neurite outgrowth of neural stem cells. Biochem Biophys Res Commun 2005; 329: 804-811.
16. Dall'Armi C, Hurtado-Lorenzo A, Tian H, Morel E, Nezu A, Chan RB et al. The phospholipase D1 pathway modulates macroautophagy. Nat Commun 2010; 1: 142.
17. Bader MF, Vitale N. Phospholipase D in calcium-regulated exocytosis: lessons from chromaffin cells. Biochim Biophys Acta 2009; 1791: 936-941.
18. Nakanishi H, Morishita M, Schwartz CL, Coluccio A, Engebrecht J, Neiman AM. Phospholipase D and the SNARE Sso1p are necessary for vesicle fusion during sporulation in yeast. J Cell Sci 2006; 119(Pt 7): 1406-1415.
19. Manjithaya R, Anjard C, Loomis WF, Subramani S. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J Cell Biol 2010; 188: 537-546.
20. Yla-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 2009; 5: 1180-1185.
21. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010; 141: 656-667.
22. Hayashi-Nishino M, Fujita N, Noda T, Yamaguchi A, Yoshimori T, Yamamoto A. Electron tomography reveals the endoplasmic reticulum as a membrane source for autophagosome formation. Autophagy 2010; 6: 301-303.
23. Ravikumar B, Moreau K, Jahreiss L, Puri C, Rubinsztein DC. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol 2010; 12: 747-757.
24. van der Vaart A, Griffith J, Reggiori F. Exit from the Golgi is required for the expansion of the autophagosomal phagophore in yeast Saccharomyces cerevisiae. Mol Biol Cell 2010; 21: 2270-2284.
25. Yen WL, Shintani T, Nair U, Cao Y, Richardson BC, Li Z et al. The conserved oligomeric Golgi complex is involved in double-membrane vesicle formation during autophagy. J Cell Biol 2010; 188: 101-114.
26. Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Res 2007; 67: 1-4.
27. Sun Y, Fang Y, Yoon MS, Zhang C, Roccio M, Zwartkruis FJ et al. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci USA 2008; 105: 8286-8291.
28. Moreau K, Ravikumar B, Puri C, Rubinsztein DC. Arf6 promotes autophagosome formation via effects on phosphatidylinositol 4, 5-bisphosphate and phospholipase D. J Cell Biol 2012; 196: 483-496.
29. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6: 352-361.
30. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441: 885-889.
31. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441: 880-884.
32. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36: 585-595.
33. Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S, Sadiq O et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet 2010; 19: 2144-2153.
34. Lee HJ, Cho ED, Lee KW, Kim JH, Cho SG, Lee SJ. Autophagic failure promotes the exocytosis and intercellular transfer of alpha-synuclein. Exp Mol Med 2013; 45: e22.
35. Venable ME, Obeid LM. Phospholipase D in cellular senescence. Biochim Biophys Acta 1999; 1439: 291-298.
36. Yoshimura S, Sakai H, Ohguchi K, Nakashima S, Banno Y, Nishimura Y et al. Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells. J Neurochem 1997; 69: 713-720.
37. France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J Neurochem 1997; 69: 1612-1621.
38. Oliveira TG, Chan RB, Tian H, Laredo M, Shui G, Staniszewski A et al. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci 2010; 30: 16419-16428.
39. Lee H-J, Lee S-J. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 2002; 277: 48976-48983.
40. Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS One 2011; 6: e19338.
41. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 2002; 58: 1801-1808.
42. Salmon DP, Thal LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology 1990; 40: 1225-1230.
43. Hansen LA, Terry RD. Position paper on diagnostic criteria for Alzheimer disease. Neurobiol Aging 1997; 18(4 Suppl): S71-S73.
44. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
45. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996; 31: 166-175.